Summary
The concentrations of probenecid and four of its metabolites have been examined in plasma and CSF by electron capture gas chromatography after extractive methylation. The plasma concentration of each of the metabolites was in the range 1,5–15 µg/ml and constituted less than 10% of the parent compound. The penetration into CSF of the metabolites was lower than that of probenecid. The concentration of each of the metabolites was below 0,2 µg/ml and the total concentration never exceeded 10% of the probenecid concentration. The inhibitory effect of the metabolites on uptake was tested in rabbit renal cortex using3H-p-amino-hippuric acid. The inhibitory effect was low. From the low activity and relatively low concentrations of the metabolites in CSF it is concluded that probenecid metabolites do not contribute to the probenecid-induced blocking effect of acid transport from the CSF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bárány, E.: Inhibition by hippurate and probenecid of in vivo uptake of iodipamide and o-iodo-hippurate. Acta Physiol. Scand.86, 12–27 (1972)
Bárány, E.: Selectivity of probenecid congeners for different organic acid transport systems in rabbit renal cortex. Acta Pharmacol. Toxicol.35, 309–316 (1974)
Dayton, P. G., Cucinell, S. A., Weiss, M., Perel, J. M.: Dose-dependence of drug plasma level decline in dogs. J. Pharmacol. Exp. Ther.158, 305–316 (1967)
Dayton, P. G., Perel, J. M., Cunningham, R. F., Israili, Z. H., Weiner, I. M.: Studies of the fate of metabolites and analogues of probenecid. Drug Metab. Dispos.6, 742–751 (1973)
Gyllenhaal, O., Näslund, B., Hartvig, P.: Determination of sulfapyridine and its N4-acetylmetabolite in plasma by gas chromatography. J. Chromatogr.156, 330 (1978)
Israili, Z. H., Perel, J. M., Cunningham, R. F., Dayton, P. G., Yü, T. F., Gutman, A. B., Long, K. R., Long, R. C., Goldstein, J. H.: Metabolites of probenecid. Chemical, physical and pharmacological studies. J. Med. Chem.15, 709–713 (1972)
Neff, N. H., Tozer, T. N., Brodie, B. B.: A specialized transport system to transfer 5HIAA directly from brain to blood. Pharmacologist6, 162–167 (1964)
Olsson, R., Roos, B.-E.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature219, 502–503 (1968)
Perel, J. M., Cunningham, R. F., Fales, H. M., Dayton, P. G.: Identification and renal excretion of probenecid metabolites in man. Life Sci.9, 1337–1343 (1970)
van Praag, H. M., Korf, J., Puite, J.: 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature225, 1259–1260 (1970)
Sjöström, R.: Cerebrospinal fluid content of 5-hydroxyindoleacetic acid and homovanillic acid in manic-depressive psychosis. Acta Universitatis Upsaliensis. Abstracts of Uppsala Dissertations from the Faculty of Medicine no 154 (1973)
Werdinius, B.: Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta Pharmacol. Toxicol.25, 18–23 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roos, B.E., Wickström, G., Hartvig, P. et al. Quantitation of CSF concentrations and biological activity of probenecid metabolites. Eur J Clin Pharmacol 17, 223–226 (1980). https://doi.org/10.1007/BF00561904
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561904